Global Women Health Rehabilitation Products Market 2017-2021


◆タイトル:Global Women Health Rehabilitation Products Market 2017-2021
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:PDF / 英語
Single User(1名利用)USD3,500 ⇒換算¥378,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。





ABSTRACTAbout Women’s Health Diagnostics

Technological advances such as integration of digital technology with diagnostic instrumentation, multiple technologies-based hematology analyzers, and quick monitoring of blood flow in deep tissues with real-time software correlators are boosting the growth of the IVD instruments market. The growing popularity of automation and technological advances have led to new product development user-friendly diagnostic instruments for laboratories and physician offices, as well as home-care settings. Manufacturers are increasingly shifting toward shortened analyzer product cycles with value-added features such as portability of instruments to stay ahead in the market.

Technavio’s analysts forecast the global women’s health diagnostics market to grow at a CAGR of 6.58% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global women’s health diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from biomarkers is considered.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Women’s Health Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott Laboratories
• F. Hoffmann-La Roche
• Hologic
• Siemens Healthineers

[Other prominent vendors]
• ACON Laboratories
• Alere
• Becton Dickinson (BD)
• bioMérieux
• Bio-Rad Laboratories
• Carl Zeiss Meditec
• Cepheid
• Danaher
• Illumina
• Mindray
• Natera
• Sysmex
• Thermo Fisher Scientific
• Urit Medical

[Market driver]
• Reimbursements for human papillomavirus (HPV) tests.
• For a full, detailed list, view our report

[Market challenge]
• High cost of mammography equipment.
• For a full, detailed list, view our report

[Market trend]
• Increased use of rapid diagnostic testing.
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market overview
• Market size and forecast
• Five forces analysis

PART 05: Market segmentation by end-users
• Overview
• Hospitals
• Clinics

PART 06: Geographical segmentation
• Overview
• Americas

PART 07: Decision framework

PART 08: Drivers and challenges
• Market drivers
• Market challenges

PART 09: Market trends
• Increasing awareness through social media marketing
• Growth in number of women in workforce
• Increase in number of private practices

PART 10: Vendor landscape
• Competitive scenario
• Industry association

PART 11: Key vendor analysis
• GE Healthcare
• GPC Medical
• Pelvic Health and Rehabilitation
• Meyer Physical Therapy
• Other prominent vendors

PART 12: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Women’s rehabilitation by type
Exhibit 02: Global women rehabilitation products market 2016-2021 ($ millions)
Exhibit 03: Factors impacting global women health rehabilitation products market
Exhibit 04: Five forces analysis
Exhibit 05: Global women rehabilitation products market by end-users 2016-2021 (% share)
Exhibit 06: Global women rehabilitation products market by end-users: Snapshot
Exhibit 07: Global women health rehabilitation products in hospitals 2016-2021 ($ millions)
Exhibit 08: Global women rehabilitation products in clinics 2016-2021 ($ millions)
Exhibit 09: Global women health rehabilitation products market by geography 2016-2021 (% share)
Exhibit 10: Global women rehabilitation products market by geography 2016-2021: Snapshot
Exhibit 11: Women health rehabilitation products market in Americas: Snapshot
Exhibit 12: Women health rehabilitation products in Americas 2016-2021 ($ millions)
Exhibit 13: Women health rehabilitation products market in EMEA: Snapshot
Exhibit 14: Women health rehabilitation products in EMEA 2016-2021 ($ millions)
Exhibit 15: Women health rehabilitation market in APAC: Snapshot
Exhibit 16: Women rehabilitation products in APAC 2016-2021 ($ millions)
Exhibit 17: Competitive parameters in global women rehabilitation products market
Exhibit 18: Strategic success factor of companies
Exhibit 19: GE Healthcare: Overview
Exhibit 20: GE Healthcare: Strength analysis
Exhibit 21: GE Healthcare: Strategy assessment
Exhibit 22: GE Healthcare: Opportunity assessment
Exhibit 23: GPC Medical: Overview
Exhibit 24: GPC Medical: Strength analysis
Exhibit 25: GPC Medical: Strategy assessment
Exhibit 26: GPC Medical: Opportunity assessment
Exhibit 27: Pelvic Health and Rehabilitation: Overview
Exhibit 28: Pelvic Health and Rehabilitation: Strength analysis
Exhibit 29: Pelvic Health and Rehabilitation: Strategy assessment
Exhibit 30: Pelvic Health and Rehabilitation: Opportunity assessment
Exhibit 31: Meyer Physical Therapy: Overview
Exhibit 32: Meyer Physical Therapy: Strength analysis
Exhibit 33: Meyer Physical Therapy: Strategy assessment
Exhibit 34: Meyer Physical Therapy: Opportunity assessment


Abbott Laboratories, F. Hoffmann-La Roche, Hologic, Siemens Healthineers, ACON Laboratories, Alere, Becton DickBulleted List Propertiesinson, bioMérieux, Bio-Rad Laboratories, Carl Zeiss Meditec, Cepheid, Danaher, Illumina, Mindray, Natera, Sysmex, Thermo Fisher Scientific, and Urit Medical.